Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
11.18
-0.04 (-0.36%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $673.14 million as of September 25, 2026. Its market cap has increased by 177.26% in one year.
Market Cap
673.14M
Enterprise Value
601.20M
1-Year Change
177.26%
Ranking
Category
Stock Price
$11.18
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $538.37M to $673.14M, an increase of 25.03%. That is a compound annual growth rate of 3.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 673.14M | 134.39% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 720.40M |
| Verastem | 706.39M |
| Nuvectis Pharma | 704.74M |
| OmniAb | 696.42M |
| Ginkgo Bioworks Holdings | 690.24M |
| MiMedx Group | 686.53M |
| Climb Bio | 682.92M |
| DBV Technologies | 673.51M |